About: Intensive Care Management of Severe Acute Liver Failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intensive Care Management of Severe Acute Liver Failure Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Intensive Care Management of Severe Acute Liver Failure
Creator	Bellomo, R Warrillow, S
Source	PMC
abstract	Severe acute liver failure is defined as the development of overt liver failure with encephalopathy over eight weeks or less in previously healthy individuals. In hyperacute liver failure, deterioration occurs in less than 14 days. Whilst it is a relatively uncommon reason for admission to the intensive care unit (ICU), acute liver failure is important because it often occurs in previously well young adults and carries a high mortality. Management of these patients presents considerable challenges within the ICU due to the extreme nature of the associated pathophysiological processes, which affect multiple systems. Integrated management strategies have been poorly studied and treatment is often center-specific [1]. Clinical manifestations include a reduced conscious state, jaundice with abnormal liver function tests (especially elevations in amino acid transferase levels more than 25 times the upper limit of normal) and coagulopathy. Further deterioration can involve marked cerebral edema, hypoglycemia and severe shock with lactic acidosis and multiple organ failure. The use of clinical management guidelines may assist in the treatment of these patients by providing an evidence-based framework for care by staff at the bedside, which ensures that all important priorities are adequately addressed. It is possible that a coordinated combination of specific and general therapies may reduce mortality and the need for liver transplantation. Consideration for transfer to a unit with expertise in liver transplantation may be appropriate in order for this option to be available as a life-saving treatment should supportive care fail to arrest deterioration.
has issue date	2015-01-01(xsd:dateTime)
bibo:doi	10.1007/978-3-319-13761-2_30
has license	no-cc
sha1sum (hex)	dbd0706c58a3635a7a562c25aa0c1f503296a032
schema:url	https://doi.org/10.1007/978-3-319-13761-2_30
resource representing a document's title	Intensive Care Management of Severe Acute Liver Failure
has PubMed Central identifier	PMC7121699
schema:publication	Annual Update in Intensive Care and Emergency Medicine 2015
resource representing a document's body	covid:dbd0706c58a3635a7a562c25aa0c1f503296a032#body_text
is schema:about of	named entity 'Management' named entity 'chronic liver disease' named entity 'pregnancy' named entity 'viral infections' named entity 'intracranial hypertension' named entity 'sodium' named entity 'Parenteral' named entity 'metabolism' named entity 'serum' named entity 'overdose' named entity 'cerebral edema' named entity 'liver' named entity 'autoimmune processes' named entity 'infusion' named entity 'hyperemia' named entity 'CNS' named entity 'acute liver failure' named entity 'acute liver failure' named entity 'major bleeding' named entity 'cerebral edema' named entity 'organ systems' named entity 'liver injury' named entity 'hemodiafiltration' named entity 'intracellular' named entity 'cerebral edema' named entity 'pancreatitis' named entity 'astrocyte' named entity 'catheters' named entity 'Central venous' named entity 'mitochondrial dysfunction' named entity 'hypothermia' named entity 'liver failure' named entity 'acute liver failure' named entity 'sepsis' named entity 'abdominal wall' named entity 'glucose' named entity 'central venous catheter' named entity 'mmol/l' named entity 'replacement fluid' named entity 'drug-induced liver injury' named entity 'water-soluble' named entity 'hyperdynamic circulation' named entity 'critical care' named entity 'hepatic dysfunction' named entity 'lower limb' named entity 'cerebral edema' named entity 'hypophosphatemia' named entity 'acute liver failure' named entity 'albumin' named entity 'edema' named entity 'metabolic' named entity 'lipase' named entity 'cerebral edema' named entity 'vasopressor' named entity 'hemodiafiltration' named entity 'EtCO' named entity 'blood lactate' named entity 'leukonychia' named entity 'normal range' named entity 'ICU' named entity 'acute liver failure' named entity 'Cerebral edema' named entity 'specific role' named entity 'ammonia' named entity 'acute hepatitis' named entity 'thrombosis' named entity 'illicit drugs' named entity 'pregnancy testing' named entity 'norepinephrine' named entity 'artificial nutrition' named entity 'critical care' named entity 'acute liver failure' named entity 'intubation' named entity 'encephalopathy' named entity 'critical illness' named entity 'autoimmune hepatitis' named entity 'Epstein-Barr virus' named entity 'acute liver failure' named entity 'drug therapies' named entity 'lactic acidosis' named entity 'multiple organ failure' named entity 'liver'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software